Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 46.80
0.00 (0.00%)
Sep 8, 2026, 1:30 PM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.16 billion as of September 8, 2026. Its market cap has decreased by -14.29% in one year.
Market Cap
3.16B
Enterprise Value
2.60B
Revenue
467.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
46.80
ChartMarket Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.16B, an increase of 995.00%. That is a compound annual growth rate of 12.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.16B | -8.77% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinew Pharma | 3.69B |
| BioGend Therapeutics | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.35B |
| BRIM Biotechnology | 3.35B |
| OBI Pharma | 3.28B |
| Shine-On BioMedical | 3.20B |
| Apex Biotechnology | 3.17B |
| Great Novel Therapeutics Biotech & Medicals | 3.15B |